Starling Oncology, Inc. Accrued Liabilities, Current
Starling Oncology, Inc. (DFPH) had Accrued Liabilities, Current of $27.43 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities, Current $27.43M.
- 2026-03-31: Accrued Liabilities, Current $24.30M.
- 2025-12-31: Accrued Liabilities, Current $20.64M.
- 2025-09-30: Accrued Liabilities, Current $22.79M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $27.43M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $24.30M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $20.64M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $22.79M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $22.89M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $23.43M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $21.09M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $15.44M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $12.83M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $18.36M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $14.00M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $12.72M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $14.13M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $12.24M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $14.60M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $16.15M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $17.61M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.52M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $13.92M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $2.63M 10-Q/A · filed 2021-12-14 | |
| 2021-06-30 | $1.52M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $80.00K 10-Q · filed 2021-05-28 | |
| 2020-12-31 | $9.45M 10-K · filed 2022-03-11 | $50.00K 10-K · filed 2021-03-30 |
| 2020-09-30 | $28.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $13.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $35.12K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $26.50K 10-K/A · filed 2021-12-14 |